Head and Neck Squamous Cell Carcinoma Clinical Trials in Westwood, Kansas

3 studies are recruiting for head and neck squamous cell carcinoma in Westwood, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

    The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling during their standard of care treatment.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Kansas, Westwood, Kansas
    Locations
    32 in total
    Run by
    Tempus AI

    See if you can join NCT06163534 on ClinicalTrials.gov

  2. Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

    This phase II trial compares the effectiveness of adding BMX-001 to usual symptom management versus usual symptom management alone for reducing oral mucositis in patients who are receiving chemoradiation for head and neck cancer. Oral mucositis (inflammation and mouth sores) is a common side effect…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
    Locations
    153 in total
    Run by
    NRG Oncology

    See if you can join NCT06532279 on ClinicalTrials.gov

  3. Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

    This phase III trial compares cetuxumab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation therapy for the treatment of patients with head and neck cancer who are unable to receive cisplatin. Cetuximab is in a class of medications called monoclonal antibodies. It binds …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
    Locations
    63 in total
    Run by
    NRG Oncology

    See if you can join NCT07441681 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.